Hydroxychloroquine Market to Reach USD 2,339.1 Million with 5.5% CAGR by 2027; Increasing Demand for the Product Will provide Impetus to Market Growth, says Fortune Business Insights™

    NEXT STORY
    Teneobio Announces US FDA Clearance of Investigational New Drug Application for TNB-486 and the Initiation of Phase I Clinical Studies in Patients with B-cell Malignancies
    PREV STORY
    WELL Health Announces $70 Million Bought Deal Financing
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Atara Biotherapeutics Presents Positive Efficacy and Safety Results for Patients with Epstein-Barr Virus-Associated Leiomyosarcoma (EBV+ LMS)

    Second EBV‑associated solid tumor with encouraging responses to tab-cel®Tab-cel® safety appears consistent with a ...

    author_avatar
    NASDAQ Market News

    Global Genetic Testing Markets, 2019-2023 – New Knowledge, Combined with Lower Pricing is Driving the Market

    author_avatar
    NASDAQ Market News

    Idera Pharmaceuticals Announces Appointment of Carol A. Schafer to its Board of Directors

    EXTON, Pa., Dec. 18, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today ...

    author_avatar
    NASDAQ Market News